Novel Melanoma Antigen Peptide and Uses Thereof

The present invention relates to novel melanoma antigen peptides and specific T lymphocytes directed to said peptides and the use thereof for treating melanoma.

Patents:
EP 2,321,340

Inventor(s): LABARRIERE NATHALIE [FR]; MOREAU-AUBRY AGNES [FR]; GODET YANN [FR]

Type of Offer: Sale



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent